Zealand's royalty deal; Khartis raises money for TED drug

💸 Khartis Therapeutics’ $50M Series B: Forge Life Science Partners, Longwood Fund, Lilly Asia Ventures and other investors backed the San Diego biotech’s latest round, which brought total funding since its ...